MENU

REGN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Regeneron Pharmaceuticals (REGN) Ownership - Who owns Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation... Show more

Industry: #Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

777 Old Saw Mill River Road

Phone

+1 914 847-7000

Employees

15410

Web

https://www.regeneron.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

64.18B

P/E Ratio

14.94

Total Cash

8.75B

Projected Growth

1.07

Total Debt

2.71B

Revenue

14.92B

Risk (Beta)

0.06

Dividend Yield

0.01

Total Cash/Share

83.50

Total Debt/Equity

24.02

Revenue/Share

138.50 USD as % of share price

View a ticker or compare two or three

VS

VS

REGN

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for REGN

A.I. Advisor

published General Information

General Information

a developer of medicines for the treatment of serious medical conditions

Industry Biotechnology

Profile

Details

Industry

Biotechnology

Address

777 Old Saw Mill River Road

Phone

+1 914 847-7000

Employees

15410

Web

https://www.regeneron.com